Dr. Jothiharan Mahenthiran, MD

Dr. Mahenthiran practices at Community Hospital East in Indianapolis, Indiana, part of Community Health Network.

Dr. Mahenthiran's NPI, 1093779910, was assigned on April 17, 2006. Dr. Mahenthiran holds Indiana license 01054396.

Dr. Mahenthiran's primary practice is Community Hospital East, at 1500 N Ritter Ave, Indianapolis, IN 46219 in Marion County. The practice phone is (317) 355-5411.

Dr. Mahenthiran's primary practice is Community Hospital East in Indianapolis, Indiana, part of Community Health Network. Dr. Mahenthiran is also affiliated with Community Hospital North. The medical group on file is Community Physician Network. Dmand AI also links Dr. Mahenthiran to 3 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mahenthiran practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mahenthiran's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Mahenthiran is licensed in Indiana.

CMS data shows 2,666 Medicare services from Dr. Mahenthiran across 25 procedure codes in 2024, for 1,540 Medicare patients. Medicare paid $79,624 for them.

CMS counts 1,540 Medicare patients who saw Dr. Mahenthiran in 2024. The largest group is 65 to 74, with 663 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mahenthiran's median patient age at 73, with 47% women.

In 2024, Dr. Mahenthiran wrote 4,476 Medicare Part D claims for 601 patients. 91% of them were for generic drugs. CMS names the drug for 4,245 of them, across 44 drugs with 11 or more claims each, at $452,758 in total drug cost. In 2023, CMS named 3,868 claims across 43 drugs.

Dr. Mahenthiran accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Mahenthiran, published from 2011 to 2021. 2012 was the busiest year, with 2. The most frequent topics are Predictive Value of Tests. Dr. Mahenthiran's most frequent co-authors are Stephen G. Sawada, MD, Masoor Kamalesh, MD and Mohsin T. Alhaddad, MD.

CMS Open Payments shows 379 general payments to Dr. Mahenthiran from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 88% of the total. Roche Health Solutions Inc. paid the most, $104,500.